Loading organizations...
Loading organizations...
Innovative circulatory assist device for heart failure patients.
Corisma has raised $27.0M across 1 funding round.
Corisma has raised $27.0M in total across 1 funding round.
Corisma has raised $27.0M in total across 1 funding round.
Corisma's investors include Grand Pharmaceutical Group.
Corisma has raised $27.0M across 1 funding round. Most recently, it raised $27.0M Series A in August 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 31, 2021 | $27.0M Series A | Grand Pharmaceutical Group |